Jasper Therapeutics, Inc. financial data

Symbol
JSPR, JSPRW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2200 Bridge Pkwy Suite #102, Redwood City, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Amplitude Healthcare Acquisition Corp (to 9/29/2021)
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.03K % +2.72%
Debt-to-equity 15 % -18.2%
Return On Equity -64.6 % +13.2%
Return On Assets -56.2 % +10.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 112M shares
Common Stock, Shares, Outstanding 15.1M shares -86.2%
Entity Public Float 111M USD +127%
Common Stock, Value, Issued 2K USD -81.8%
Weighted Average Number of Shares Outstanding, Basic 13.3M shares +51.7%
Weighted Average Number of Shares Outstanding, Diluted 13.3M shares +51.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 52.3M USD +44.2%
General and Administrative Expense 17.7M USD +9.84%
Operating Income (Loss) -70M USD -33.7%
Nonoperating Income (Expense) 1.34M USD
Net Income (Loss) Attributable to Parent -63.9M USD -28.5%
Earnings Per Share, Basic -5.59 USD/shares +53%
Earnings Per Share, Diluted -5.59 USD/shares +53%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 118M USD -8.44%
Marketable Securities, Current 3.4M USD
Other Assets, Current 440K USD -39%
Assets, Current 120M USD -9.21%
Property, Plant and Equipment, Net 2.46M USD -25.8%
Operating Lease, Right-of-Use Asset 1.35M USD -24.4%
Other Assets, Noncurrent 1.42M USD +96.3%
Assets 126M USD -9.22%
Accounts Payable, Current 2.39M USD -37.8%
Employee-related Liabilities, Current 771K USD +53.9%
Liabilities, Current 8.92M USD +13%
Operating Lease, Liability, Noncurrent 1.55M USD -39.2%
Other Liabilities, Noncurrent 2.26M USD -2.87%
Liabilities 12.7M USD -6.09%
Retained Earnings (Accumulated Deficit) -183M USD -53.5%
Stockholders' Equity Attributable to Parent 113M USD -9.56%
Liabilities and Equity 126M USD -9.22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.7M USD -52.3%
Net Cash Provided by (Used in) Financing Activities 47.3M USD -53.4%
Net Cash Provided by (Used in) Investing Activities -25K USD +3.85%
Common Stock, Shares Authorized 492M shares 0%
Common Stock, Shares, Issued 15.1M shares -86.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 119M USD -8.42%
Deferred Tax Assets, Gross 47M USD +36.1%
Operating Lease, Liability 2.55M USD
Lessee, Operating Lease, Liability, to be Paid 2.8M USD
Property, Plant and Equipment, Gross 5.21M USD +5.38%
Operating Lease, Liability, Current 1M USD +12.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 740K USD -35.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.19M USD +40.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 242K USD -93.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 740K USD -37.7%
Deferred Tax Assets, Operating Loss Carryforwards 25.1M USD +21.7%
Deferred Federal Income Tax Expense (Benefit) -13.5M USD -71.1%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.42M USD +40.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 740K USD
Operating Lease, Payments 285K USD +3.26%
Additional Paid in Capital 297M USD +21.3%
Depreciation, Depletion and Amortization 1.11M USD +13.6%
Deferred Tax Assets, Net of Valuation Allowance 488K USD -13.3%
Share-based Payment Arrangement, Expense 1.17M USD -7.74%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%